If you suffered losses exceeding $100,000 in AstraZeneca between between February 23, 2022 and December 17, 2024 and would ...

In a report released today, Emily Field from Barclays maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target of ...

Shares of AstraZeneca PLC AZN slipped 1.77% to £106.30 Tuesday, on what proved to be an all-around poor trading session for ...

AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

The AstraZeneca PLC ADR AZN slipped 0.55% to $65.37 Tuesday, on what proved to be an all-around mixed trading session for the ...

AstraZeneca has sued a handful of drug companies to protect its cancer treatment drug, Lynparza. The suits, which were filed by attorneys with Gibbons and Williams & Connolly, seek to protect the ...

Synthego, a leading supplier of CRISPR solutions, has entered a strategic licensing agreement with global biopharmaceutical company AstraZeneca. This agreement grants Synthego a global license to ...

Although headquartered in the UK, AstraZeneca is still known as the 'Anglo-Swedish pharma company', having been created from the merger of the British Zeneca and Sweden's Astra in 1999.

NEW YORK, USA - - 14 January 2025 – The highly anticipated Best Places to Work World Rankings for 2024 have been revealed, ...

AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 17,268.38 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...

The UK's self-regulated system for disclosing payments from drug companies to healthcare professionals and organizations is ...